Related Experiment Videos
[Personal experience with ovarian dysgerminoma]
Jugoslavenska Ginekologija I Opstetricija
|May 1, 1982
Summary
Ovarian dysgerminoma treatment yielded unsatisfactory results, with most patients presenting with advanced disease. While surgery, radiotherapy, and chemotherapy were used, individualized treatment is crucial for this rare ovarian cancer.
Area of Science:
- Gynecologic Oncology
- Radiation Oncology
- Medical Oncology
Context:
- Ovarian dysgerminoma is a rare germ cell tumor of the ovary.
- This study examines treatment outcomes for 11 patients diagnosed with ovarian dysgerminoma.
- The majority of patients presented with advanced-stage disease at diagnosis.
Purpose:
- To evaluate the treatment outcomes and survival rates of patients with ovarian dysgerminoma.
- To assess the efficacy of multimodal treatment including surgery, radiotherapy, and chemotherapy.
- To highlight the importance of individualized treatment strategies for ovarian dysgerminoma.
Summary:
- Eleven patients with ovarian dysgerminoma underwent treatment, with most diagnosed at advanced stages.
- Treatment involved surgery, radiotherapy (effective due to radiosensitivity), and chemotherapy.
- Survival outcomes were poor, with only three patients surviving long-term (8-12 years); others had poor prognoses or died within months.
Impact:
- The study underscores the challenges in treating advanced ovarian dysgerminoma.
- It emphasizes the radiosensitivity of this tumor and the potential role of adjuvant therapies.
- Findings suggest a need for tailored therapeutic approaches, especially considering the disease affects younger women.